A. Community acquired pneumonia
|
|
Bacterial |
Streptococcus pneumoniae |
Haemophilus influenzae |
Legionella spp. |
Mycoplasma pneumoniae |
Chlamydia pneumoniae |
Staphylococcus aureus |
Klebsiella pneumoniae |
Viral |
Influenza virus |
Respiratory Syncytial virus |
Metapneumovirus |
Coronavirus |
Rhinovirus |
Adenovirus |
Other |
Mycobacterium tuberculosis—in TB endemic areas |
B. Hospital acquired pneumonia |
In addition to pathogens implicated in CAP |
Pseudomonas aeruginosa |
Acinetobacter baumannii |
Stenotrophomonas maltophilia |
Enterobacteriaceae |
Methicillin-resistant S. aureus
|
C. Immunocompromised host |
In addition to pathogens implicated in CAP and HAP: |
Fungal |
Pneumocystis jirovecii |
Aspergillus spp. |
Cryptococcus neoformans |
Endemic fungi e.g., histoplasmosis, cocciodiomycosis (geographically restricted) |
Viral |
Cytomegalovirus |
Varicella |
Herpes |
Parasitic |
Strongyloides stercoralis |
Toxoplasma gondii |
Bacterial |
Nocardia asteroides |
Rhodococcus eui |
Bordetella pertussis |
Pasteurella multocida |
Mycobacterial |
Mycobacterium tuberculosis |
Non-tuberculous mycobacteria |